|
| | | Expression | |
| Protein | Function | Reference | Mass | Western | Cancer-related studies |
|
| Upregulated expression | | | | | |
|
| Sulfhydryl oxidase 1 | Catalyze disulfide bond formation | [25] | | | [26, 27] |
| Glia-derived nexin | Serine protease inhibitor | [8] | | | [28, 29] |
| Seminal vesicle secretory protein 1 | Amine oxidase activity/Copulatory plug formation | [5] | | | — |
| Seminal vesicle secretory protein 3a | Copulatory plug formation | [19] | | | — |
| Seminal vesicle secretory protein 3β | Copulatory plug formation | [30] | | | — |
| Seminal vesicle secretory protein 6 | Serine proteinase inhibitor | [31] | | — | [32] |
|
| Downregulated expression | | | | | |
|
| Seminal vesicle secretory protein 2 | Semen-coagulating protein/Sperm decapacitation factor | [6, 33] | | | [34] |
| Carcinoembryonic antigen-related cell adhesion molecule 10 | Sperm binding and enhancement of sperm motility | [7] | | | — |
| Lysozyme C, type M | Primary bacteriolysis | — | | | — |
| Seminal vesicle secretory protein 5 | Serine proteinase inhibitor | [35] | | | — |
| Secreted seminal-vesicle Ly-6 protein 1 | Potential cellular adhesion and signaling | [21] | | | — |
| Seminal vesicle secretory protein 7 | Sperm capacitation factor | [20] | | | — |
| Serine protease inhibitor kazal-like protein | Serine protease inhibitor/Sperm decapacitation factor | [22] | | | — |
| Serine protease inhibitor Kazal-type 3 | Serine protease inhibitor/Sperm decapacitation factor | [9] | | | — |
| Seminal vesicle antigen | Sperm decapacitation factor | [36] | | — | — |
| Seminal vesicle secretory protein 4 | Anti-inflammatory and immune-modulating agent | [37] | | — | — |
|
